FDA
-
-
-
-
-
-
-
MeiraGTx acquires gene therapy bota-vec from Johnson & Johnson
-
-
-
-
-
-
-
MeiraGTx Holdings plc (MGTX) PT Raised to $16 at BofA Securities
-
-
-
-
-
-
-
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
-
-
-
-
-
-
-
MeiraGTx Holdings plc (MGTX) PT Raised to $13 at RBC Capital; 'PD Deal Looks Good To Us'
-
-
-
-
-
-
-
MeiraGTx Holdings plc (MGTX) Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
-
-
-
-
-
-
-
MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference
-
-
-
-
-
-
-
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
-
328,603 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

